A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

Overview of attention for article published in BMC Cancer, December 2013

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 64 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 22,822 followers.

Phase II trial: Peptide vaccination in castration-resistant #prostatecancer: prolongation of #PSA doubling time. http://t.co/co4cwfGh6b

Reply Repost Favourite

A surrogate marker for evaluating the effectiveness of a prostrate #cancer vaccine http://t.co/F3Mored5Lo

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.